| Literature DB >> 27016318 |
Paolo Machi1, Franck Jourdan2, Dominique Ambard2, Cedric Reynaud2, Kyriakos Lobotesis3, Mathieu Sanchez2, Alain Bonafé1, Vincent Costalat1.
Abstract
BACKGROUND: Five randomized controlled trials recently appeared in the literature demonstrating that early mechanical thrombectomy in patients with acute ischemic stroke is significantly related to an improved outcome. Stent retrievers are accepted as the most effective devices for intracranial thrombectomy.Entities:
Keywords: Stent; Stroke; Thrombectomy
Mesh:
Year: 2016 PMID: 27016318 PMCID: PMC5339553 DOI: 10.1136/neurintsurg-2015-012213
Source DB: PubMed Journal: J Neurointerv Surg ISSN: 1759-8478 Impact factor: 5.836
List of thrombectomy devices evaluated in this study
| Device | Size* |
|---|---|
| Trevo Provue (Stryker, Kalamazoo, Michigan, USA)† | 4–20/3–20 |
| Catch (Balt, Montmorency, France)‡ | 3–15/4–20/6–30 |
| Eric (Microvention, Aliso Viejo, California, USA)† | 3–20/4–24/6–44 |
| Preset (Phenox, Bochum, Germany)‡ | 4–20/6–30 |
| Preset LT (Phenox, Bochum, Germany)‡ | 3–20/4–20 |
| Embotrap (Nauravi, Galway, Ireland)† | 5–21 |
| Separator 3D (Penumbra Inc, Alameda, California, USA)† | 4.5–26 |
| Revive (Codman, Raynham, Massachusetts, USA)† | 4.5–22 |
| Mindframe (Medtronic, Irvine, California, USA)† | 3–23 |
| Solitaire FR (Medtronic, Irvine, California, USA)‡ | 4–20/6–30 |
*For each device, the first value refers to the nominal diameter, the second value refers to the length expressed in mm.
†Complete axial section device.
‡Incomplete axial section device.
Figure 1The rigid 3D printed model used for the experiments.
Figure 2‘Pull up traction test’ setting: the figure shows a stent retriever deployed within a silicone tube maintained by a rigid scaffold; the push wire is connected to the traction transducer arm of the tensile test machine.
Result of Flat plate tests and Pull up traction tests
| Size | |||
|---|---|---|---|
| Trevo PV | |||
| 4–20 | 0.01480 | 920 | 50* (p=0.050) |
| 3–20 | 0.00600 | 300 | 60* (p=0.030) |
| Eric | |||
| 3–20 | 0.01100 | 220 | – |
| 4–24 | 0.01850 | 1540 | 340* (p=0.008) |
| 6–44 | 0.01304 | 770 | 400* (p=0.010) |
| Embotrap | |||
| 5–21 | 0.00642 | 1430 | 770* (p=0.014) |
| Separator 3D | |||
| 4.5–26 | 0.00791 | 1360 | 400* (p=0.006) |
| Revive | |||
| 4.5–22 | 0.01269 | 1360 | 850* (p=0.021) |
| Mindframe | |||
| 3–23 | 0.00451 | 1250 | 330* (p=0.034) |
| Solitaire FR | |||
| 4–20 | 0.00448 | 1110 | 530* (p=0.014) |
| 6–30 | 0.00351 | 1060 | 580* (p=0.020) |
| Preset | |||
| 4–20 | 0.00521 | 1090 | 730* (p=0.018) |
| 6–30 | 0.00368 | 630 | 600* (p=0.25) |
| Preset LT | |||
| 3–20 | 0.00320 | 1060 | 160* (p=0.03) |
| 4–20 | 0.00370 | 460 | 480* (p=0.77) |
| Catch | |||
| 3–15 | 0.00350 | 840 | 220* (p=0.049) |
| 4–20 | 0.00444 | 1810 | 360* (p=0.010) |
| 6–30 | 0.00368 | 1870 | 900* (p=0.030) |
*p Value for the comparison between force exerted in tubes of 1.5 and 3.5 mm inner diameter during Pull up traction tests. Note results obtained with Preset 6–30 and Preset LT 4–20 for which there is not significant shift of the radial pressure when retrieved in tubes of different diameter; p=0.25 and p=0.77, respectively.
Results of Retrieving tests
| Device | Size | Close apposition | Elongation | Loss of contact |
|---|---|---|---|---|
| Trevo PV | 4–20 | + | ||
| 3–20 | + | |||
| Eric | 3–20 | + | ||
| 4–24 | + | |||
| 6–44 | + | |||
| Embotrap | 5–21 | + | ||
| Separator 3D | 4.5–26 | + | ||
| Revive | 4.5–22 | + | ||
| Mindframe | 3–23 | + | ||
| Solitaire FR | 4–20 | + | ||
| 6–30 | + | |||
| Preset | 4–20 | + | ||
| 6–30 | + | |||
| Preset LT | 3–20 | + | ||
| 4–20 | + | |||
| Catch | 3–15 | + | ||
| 4–20 | + | |||
| 6–30 | + |
Figure 3Some devices showed a greater degree of elongation around acute vessel angles: interaction of the proximal, middle, and distal thirds of Solitaire 4–20 (A–C).
Results of in vitro thrombectomies
| Device | Size | Large white clot | Medium white clot | Small white clot | % | Large red clot | Medium red clot | Small red clot | % |
|---|---|---|---|---|---|---|---|---|---|
| Trevo PV | 4–20 | 0/5 | 2/5 | 3/5 | 33 | 3/5 | 4/5 | 5/5 | 80 |
| 3–20 | 0/5 | 1/5 | 2/5 | 20 | 3/5 | 3/5 | 3/5 | 60 | |
| Eric | 3–20 | 0/5 | 1/5 | 2/5 | 20 | 3/5 | 3/5 | 2/5 | 53 |
| 4–24 | 0/5 | 2/5 | 3/5 | 33 | 2/5 | 3/5 | 4/5 | 60 | |
| 6–44 | 0/5 | 3/5 | 3/5 | 40 | 2/5 | 5/5 | 4/5 | 73 | |
| Embotrap | 5–21 | 1/5* | 2/5 | 3/5 | 40 | 3/5 | 5/5 | 4/5 | 80 |
| Separator 3D | 4.5–26 | 0/5 | 2/5 | 2/5 | 26 | 2/5 | 2/5 | 3/5 | 46 |
| Revive | 4.5–22 | 1/5* | 2/5 | 3/5 | 40 | 3/5 | 5/5 | 4/5 | 80 |
| Mindframe | 3–23 | 0/5 | 2/5 | 2/5 | 26 | 3/5 | 4/5 | 3/5 | 66 |
| Solitaire FR | 4–20 | 0/5 | 3/5 | 3/5 | 40 | 4/5 | 5/5 | 5/5 | 93‡ |
| 6–30 | 1/5* | 3/5 | 4/5 | 53 | 4/5 | 5/5 | 5/5 | 93‡ | |
| Preset | 4–20 | 0/5 | 3/5 | 4/5 | 46 | 4/5 | 5/5 | 5/5 | 93‡ |
| 6–30 | 2/5* | 3/5 | 4/5 | 60† | 5/5 | 5/5 | 5/5 | 100§ | |
| Preset LT | 3–20 | 0/5 | 1/5 | 2/5 | 20 | 3/5 | 2/5 | 3/5 | 53 |
| 4–20 | 0/5 | 2/5 | 2/5 | 26 | 3/5 | 3/5 | 3/5 | 60 | |
| Catch | 3–15 | 0/5 | 1/5 | 2/5 | 20 | 2/5 | 3/5 | 3/5 | 53 |
| 4–20 | 1/5* | 1/5 | 2/5 | 26 | 3/5 | 3/5 | 3/5 | 60 | |
| 6–30 | 1/5* | 3/5 | 4/5 | 53 | 5/5 | 5/5 | 4/5 | 93‡ |
*Minimal clot displacement.
†The rate of white clot removal found for Preset 6–30 was significantly higher than the rates for Catch 3–15, Preset LT 3–20, Eric 3–20, and Trevo 3–20 (60% vs 20%; p=0.031).
‡The rate of red clot removal found for Solitaire 4–20/6–30, Preset 4–20, and Catch 6–30 was significantly higher than the rates for Separator 3D, Eric 3–20, Preset LT 3–20, and Catch 3–15 (93% vs 46%; p=0.016 or 93% vs 53%; p=0.031).
§The rate of red clot removal found for Preset 6–30 was significantly higher than the rates for Separator 3D (100% vs 46%; p=0.008), Eric 3–20, Preset LT 3–20, Catch 3–15 (100% vs 53%; p=0.016), Trevo 3–20, and Eric 4–24 (100% vs 60%; p=0.031).
Figure 4Interaction between Solitaire 4–20 and a large white clot: interaction of the proximal, middle, and distal thirds of the device (A–C).